sofosbuvir-velpatasvir drug combination: Clinical Trials

4 trials of sofosbuvir-velpatasvir drug combination, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow sofosbuvir-velpatasvir drug combination: new trials by email Literature Review of sofosbuvir-velpatasvir drug combination trials Research Report on sofosbuvir-velpatasvir drug combination

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Chronic Hepatitis C During Pregnancy With Sofosbuvir/Velpatasvir
Sofosbuvir-Velpatasvir Drug Combination - Hepatitis C, Chronic
Phase 1CompletedCatherine Anne Chappell112020-10-222025-01-01
Expanding the Pool in Lung Transplantation
Epclusa - Hepatitis C, Lung Transplant
Phase 1CompletedPablo Sanchez102019-07-302022-12-16
Transplanting Hepatitis C Lungs Into Negative Lung Recipients
Zepatier, Epclusa - Lung Diseases
Phase 1 / Phase 2CompletedUniversity of Pennsylvania102018-12-122023-04-14
Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol
SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol - HCV Infection
Phase 1CompletedGilead Sciences152015-10-292020-09-02

Conditions studied

Hepatitis C (2)  ·  Hepatitis C, Chronic (1)  ·  Lung Diseases (1)

Sponsors

Catherine Anne Chappell (1)  ·  Gilead Sciences (1)  ·  Pablo Sanchez (1)  ·  University of Pennsylvania (1)

Countries

United States (3)  ·  New Zealand (1)

Top investigators

Catherine Chappell, MD, MSc (1)  ·  Pablo Sanchez, MD (1)  ·  Peter Reese, MD, MSCE (1)

NIH funding

R21HD101996 (1)